0.06 - 0.07
0.06 - 0.24
4.46M / 3.59M (Avg.)
-1.65 | -0.04
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
2237559.31%
10Y revenue/share CAGR above 1.5x NHC.AX's 350.69%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
No Data
No Data available this quarter, please select a different quarter.
598.36%
3Y revenue/share CAGR above 1.5x NHC.AX's 192.13%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
198.47%
OCF/share CAGR of 198.47% while NHC.AX is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
192.69%
5Y OCF/share CAGR at 50-75% of NHC.AX's 381.47%. Martin Whitman would question if the firm lags in monetizing revenue effectively.
642.62%
3Y OCF/share CAGR 1.25-1.5x NHC.AX's 491.70%. Bruce Berkowitz might see if strategic cost controls or product mix drove recent gains.
106.66%
Positive 10Y CAGR while NHC.AX is negative. John Neff might see a substantial advantage in bottom-line trajectory.
104.59%
Below 50% of NHC.AX's 432.36%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
101.24%
Below 50% of NHC.AX's 4691.20%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
No Data
No Data available this quarter, please select a different quarter.
-93.72%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
123.55%
3Y equity/share CAGR above 1.5x NHC.AX's 17.02%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.